Subsidiary (BVI) Clitina International Limited
cash capital injection approved by BOD of
CHLITINA HOLDING LIMITED
Date of events
2022/03/10
To which item it meets
paragraph 11
Statement
1.Date of the board of directors resolution:2022/03/10
2.Source of capital increase funds:capital increase by cash
3.Whether to adopt shelf registration (Yes, please state issuance period/No):
No.
4.Total monetary value of the issuance and number of shares issued (shares
issued not including those distributed to employees if consisting in
capital increase from earnings or capital surplus):USD4,000,000
5.If adopting shelf registration, monetary value and number of shares
to be issued this time:NA
6.The remaining monetary value and shares after this issuance when
adopting shelf registration:NA
7.Par value per share:USD1
8.Issue price:issued by par value per share
9.Number of shares subscribed for by or allocated to employees:None.
10.Number of shares publicly sold:NA
11.Ratio of shares subscribed by or allotted as stock dividends to existing
shareholders:NA
12.Handling method for fractional shares and shares unsubscripted for by
the deadline:NA
13.Rights and obligations of these newly issued shares:
The rights and obligations of the newly issued common shares are
the same as the existing common shares.
14.Utilization of the funds from the capital increase:
Invest in K&S Biomedical Ltd..
15.Any other matters that need to be specified:
(1)The capital injection flow is as follows: (BVI) Chlitina Holding Limited
→ (BVI) Chlitina Group Limited → (BVI) Chlitina International Limited.
The capital increase amount does not reach the threshold set by the TWSE
for public disclosure and therefore will not be announced.
(2)The chairman is authorized by the BoD to handle relevant matters such as
the date of the capital injection.
(3)This case is to authorize the chairman to reinvest in
"K&S Biomedical Ltd." in batches within the quota of NT$100,000,000,
depending on the operational situation, and implement the development
plan of the new channel in Taiwan.
(4)(BVI) Chlitina Group Limited and (BVI) Chlitina International Limited
are all 100%-owned by parent company.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chlitina Holding Ltd. published this content on 10 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 March 2022 14:03:10 UTC.
Chlitina Holding Ltd is a Taiwan-based company principally engaged in the research, development, manufacture and sale of beauty products and skin care packages. The Company's main products include facial care products, body products and aromatic products. The Company is also involved in the operation and promotion of franchise beauty chain stores. The Company distributes its products in domestic market and to overseas markets, such as mainland China and Hong Kong.
CHLITINA HOLDING LIMITED 
